CNBX PHARMACEUTICALS INC. (CNBX) Financial Statements
CNBX PHARMACEUTICALS INC. (CNBX) files with the U.S. Securities and Exchange Commission under CIK 0001343009. 10KGenie shows its annual and quarterly statements from SEC filings.
Key Figures, Fiscal Year 2025
- Revenue
- $0
- Net Income
- -$313.98 thousand
- Total Assets
- $18.44 thousand
- Net Cash from Operations
- -$171.31 thousand
Fiscal year ended Aug 31, 2025. Latest periodic SEC filing: Jun 24, 2026. Source: SEC filings (EDGAR XBRL).
Open the full financial statements for CNBX in 10KGenie
Data from SEC EDGAR filings. 10KGenie is not affiliated with the SEC. SEC Filing History